Avalo Therapeutics Statistics
Total Valuation
AVTX has a market cap or net worth of $51.54 million. The enterprise value is -$72.71 million.
Important Dates
The next estimated earnings date is Monday, August 11, 2025, before market open.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVTX has 10.83 million shares outstanding. The number of shares has increased by 1,963.09% in one year.
| Current Share Class | 10.83M |
| Shares Outstanding | 10.83M |
| Shares Change (YoY) | +1,963.09% |
| Shares Change (QoQ) | +2.77% |
| Owned by Insiders (%) | 5.85% |
| Owned by Institutions (%) | 25.56% |
| Float | 3.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 73.83 |
| Forward PS | n/a |
| PB Ratio | 0.42 |
| P/TBV Ratio | 0.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.61, with a Debt / Equity ratio of 0.01.
| Current Ratio | 22.61 |
| Quick Ratio | 22.27 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 678.24% and return on invested capital (ROIC) is -260.33%.
| Return on Equity (ROE) | 678.24% |
| Return on Assets (ROA) | -23.98% |
| Return on Invested Capital (ROIC) | -260.33% |
| Return on Capital Employed (ROCE) | -37.85% |
| Revenue Per Employee | $19,174 |
| Profits Per Employee | $3.17M |
| Employee Count | 23 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTX has paid $115,000 in taxes.
| Income Tax | 115,000 |
| Effective Tax Rate | 0.16% |
Stock Price Statistics
The stock price has decreased by -65.74% in the last 52 weeks. The beta is 0.71, so AVTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -65.74% |
| 50-Day Moving Average | 4.44 |
| 200-Day Moving Average | 7.82 |
| Relative Strength Index (RSI) | 54.24 |
| Average Volume (20 Days) | 100,889 |
Short Selling Information
The latest short interest is 83,831, so 0.77% of the outstanding shares have been sold short.
| Short Interest | 83,831 |
| Short Previous Month | 46,915 |
| Short % of Shares Out | 0.77% |
| Short % of Float | 2.20% |
| Short Ratio (days to cover) | 0.92 |
Income Statement
In the last 12 months, AVTX had revenue of $441,000 and earned $73.01 million in profits.
| Revenue | 441,000 |
| Gross Profit | -20.36M |
| Operating Income | -50.31M |
| Pretax Income | -142.87M |
| Net Income | 73.01M |
| EBITDA | -50.04M |
| EBIT | -50.31M |
| Earnings Per Share (EPS) | -$4.90 |
Full Income StatementBalance Sheet
The company has $125.05 million in cash and $801,000 in debt, giving a net cash position of $124.25 million or $11.47 per share.
| Cash & Cash Equivalents | 125.05M |
| Total Debt | 801,000 |
| Net Cash | 124.25M |
| Net Cash Per Share | $11.47 |
| Equity (Book Value) | 122.62M |
| Book Value Per Share | 11.32 |
| Working Capital | 121.33M |
Full Balance SheetCash Flow
| Operating Cash Flow | -52.31M |
| Capital Expenditures | n/a |
| Free Cash Flow | -52.31M |
| FCF Per Share | -$4.83 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -11,408.39% |
| Pretax Margin | 16,582.09% |
| Profit Margin | 16,556.01% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,963.09% |
| Shareholder Yield | -1,963.09% |
| Earnings Yield | 141.66% |
| FCF Yield | -101.50% |
Analyst Forecast
The average price target for AVTX is $31.00, which is 551.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.00 |
| Price Target Difference | 551.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 85.64% |
| EPS Growth Forecast (5Y) | -29.50% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 29, 2023. It was a reverse split with a ratio of 0.0041667:1.
| Last Split Date | Dec 29, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.0041667:1 |
Scores
AVTX has an Altman Z-Score of -1.66 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.66 |
| Piotroski F-Score | 2 |
